Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 206

Similar articles for PubMed (Select 21256633)

1.

[Injection of botulinum toxin (BTX-A) in children with bladder dysfunction due to detrusor overactivity].

Romero RM, Rivas S, Parente A, Fanjul M, Angulo JM.

Actas Urol Esp. 2011 Feb;35(2):89-92. doi: 10.1016/j.acuro.2010.08.005. Epub 2011 Jan 21. Spanish.

PMID:
21256633
2.

Intravesical electromotive botulinum toxin type A administration--part II: Clinical application.

Kajbafzadeh AM, Ahmadi H, Montaser-Kouhsari L, Sharifi-Rad L, Nejat F, Bazargan-Hejazi S.

Urology. 2011 Feb;77(2):439-45. doi: 10.1016/j.urology.2010.06.003. Epub 2010 Aug 30.

PMID:
20800886
3.

Efficacy of botulinum toxin A injection for neurogenic detrusor overactivity and urinary incontinence: a randomized, double-blind trial.

Herschorn S, Gajewski J, Ethans K, Corcos J, Carlson K, Bailly G, Bard R, Valiquette L, Baverstock R, Carr L, Radomski S.

J Urol. 2011 Jun;185(6):2229-35. doi: 10.1016/j.juro.2011.02.004. Epub 2011 Apr 16.

PMID:
21497851
4.

Botulinum toxin-A injections into neurogenic overactive bladder--to include or exclude the trigone? A prospective, randomized, controlled trial.

Abdel-Meguid TA.

J Urol. 2010 Dec;184(6):2423-8. doi: 10.1016/j.juro.2010.08.028. Epub 2010 Oct 16.

PMID:
20952003
5.
6.

Repeat botulinum toxin-A injections for treatment of adult detrusor overactivity.

Dowson C, Khan MS, Dasgupta P, Sahai A.

Nat Rev Urol. 2010 Dec;7(12):661-7. doi: 10.1038/nrurol.2010.187. Review.

PMID:
21139642
7.

Adverse events of intravesical botulinum toxin a injections for idiopathic detrusor overactivity: risk factors and influence on treatment outcome.

Kuo HC, Liao CH, Chung SD.

Eur Urol. 2010 Dec;58(6):919-26. doi: 10.1016/j.eururo.2010.09.007. Epub 2010 Sep 17.

PMID:
20864251
8.

Long-term effect on quality of life of repeat detrusor injections of botulinum neurotoxin-A for detrusor overactivity in patients with multiple sclerosis.

Khan S, Game X, Kalsi V, Gonzales G, Panicker J, Elneil S, Apostolidis A, Hamid R, Dasgupta P, Kessler TM, Fowler CJ.

J Urol. 2011 Apr;185(4):1344-9. doi: 10.1016/j.juro.2010.12.002. Epub 2011 Feb 22.

PMID:
21334639
9.

[Input from a specialized nurse consultation in the management of detrusor overactivity treated with intradetrusor injections of botulinum toxin in urology department. Pilot study].

Le Gal S, Safsaf A, Galliot I, Catovic B, Grise P.

Prog Urol. 2010 Sep;20(8):584-9. doi: 10.1016/j.purol.2010.01.012. Epub 2010 Mar 29. French.

PMID:
20832036
10.

Efficacy and tolerability of botulinum toxin type A in patients with neurogenic detrusor overactivity and without concomitant anticholinergic therapy: comparison of two doses.

Grise P, Ruffion A, Denys P, Egon G, Chartier Kastler E.

Eur Urol. 2010 Nov;58(5):759-66. doi: 10.1016/j.eururo.2010.06.035. Epub 2010 Jul 3.

PMID:
20674149
11.

Meta-analysis of botulinum toxin A detrusor injections in the treatment of neurogenic detrusor overactivity after spinal cord injury.

Mehta S, Hill D, McIntyre A, Foley N, Hsieh J, Ethans K, Teasell RW, Loh E, Welk B, Wolfe D.

Arch Phys Med Rehabil. 2013 Aug;94(8):1473-81. doi: 10.1016/j.apmr.2013.04.011. Epub 2013 Apr 28. Review.

PMID:
23632286
12.

The use of botulinum toxin a in idiopathic overactive bladder syndrome.

Gomez CS, Kanagarajah P, Gousse A.

Curr Urol Rep. 2010 Sep;11(5):353-9. doi: 10.1007/s11934-010-0134-4. Review.

PMID:
20623260
13.

Botulinum toxin injection: a review of injection principles and protocols.

Rapp DE, Lucioni A, Bales GT.

Int Braz J Urol. 2007 Mar-Apr;33(2):132-41. Review.

14.

Antibodies after botulinum toxin A injection into musculus detrusor vesicae: incidence and clinical relevance.

Hegele A, Frohme C, Varga Z, Olbert P, Kranz J, Hofmann R.

Urol Int. 2011;87(4):439-44. doi: 10.1159/000332194. Epub 2011 Oct 18.

PMID:
22004911
15.

Botulinum toxin A submucosal injection for refractory non-neurogenic overactive bladder: early outcomes.

Okamura K, Nojiri Y, Ameda K, Namima T, Suzuki M, Inoue K, Ogawa T, Gotoh M, Homma Y.

Int J Urol. 2011 Jun;18(6):483-7. doi: 10.1111/j.1442-2042.2011.02768.x. Epub 2011 Apr 13.

PMID:
21488978
16.

Discontinuation rates and inter-injection interval for repeated intravesical botulinum toxin type A injections for detrusor overactivity.

Veeratterapillay R, Harding C, Teo L, Vasdev N, Abroaf A, Dorkin TJ, Pickard RS, Hasan T, Thorpe AC.

Int J Urol. 2014 Feb;21(2):175-8. doi: 10.1111/iju.12205. Epub 2013 Jul 2.

PMID:
23819724
17.

Urodynamic assessment of children treated with botulinum toxin A injections for urge incontinence: a pilot study.

Lahdes-Vasama TT, Anttila A, Wahl E, Taskinen S.

Scand J Urol Nephrol. 2011 Dec;45(6):397-400. doi: 10.3109/00365599.2011.590997. Epub 2011 Jul 8.

PMID:
21740110
18.

Intravesical instillation of botulinum toxin A: an in vivo murine study and pilot clinical trial.

Krhut J, Zvara P.

Int Urol Nephrol. 2011 Jun;43(2):337-43. doi: 10.1007/s11255-010-9790-z. Epub 2010 Jun 20.

PMID:
20563845
19.

Intravesical botulinum type-A toxin (Dysport®) in the treatment of idiopathic detrusor overactivity in children.

Blackburn SC, Jones C, Bedoya S, Steinbrecher HA, Malone PS, Griffin SJ.

J Pediatr Urol. 2013 Dec;9(6 Pt A):750-3. doi: 10.1016/j.jpurol.2012.08.011. Epub 2012 Oct 1.

PMID:
23036518
20.

Botulinum toxin treatment for bladder dysfunction.

Santos-Silva A, da Silva CM, Cruz F.

Int J Urol. 2013 Oct;20(10):956-62. doi: 10.1111/iju.12188. Epub 2013 May 2. Review.

PMID:
23634720
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk